Clinical trials: Reticular Pseudodrusen
Reticular Pseudodrusen (RPD), Age-Related Macular Degeneration
Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation
Background: Age-related macular degeneration (AMD) is an eye disease. It is the leading cause of vision loss in people over 55 in the U.S. Changes in the eye can make it difficult for they eye to adjust to low light.
- Trial name
- NCT03478878
- Testing
- Vitamin A Palmitate
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- National Eye Institute (NEI)
AMD
Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation
Background: Age-related macular degeneration (AMD) is an eye disease. It is the leading cause of vision loss in people over 55 in the U.S. Changes in the eye can make it difficult for the eye to adjust to low light.
- Trial name
- NCT03478865
- Testing
- Vitamin A palmitate
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- National Eye Institute (NEI)
Age-Related Macular Degeneration, Geographic Atrophy
Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD
To evaluate the effectiveness of subthreshold laser treatment on retinal sensitivity in patients with reticular pseudodrusen and incipient Geographic Atrophy (GA) secondary to Age-Related Macular Degeneration (AMD).
- Conditions
- Age-Related Macular Degeneration, Geographic Atrophy, Reticular Pseudodrusen
- Trial name
- NCT02800356
- Testing
- Subthreshold 577 nm yellow wavelength laser photo-coagulator
- Where
- Italy
- Volunteers
- 20 people
- Sponsor
- Ospedale San Raffaele